TMEM236 and colorectal cancer: Past studies have understood the TMEM236 highly expressed in pancreatic α cells that secrete glucagon, elevating blood glucose, also considered to be a potential novel diagnostic biomarker for colorectal cancer, due to significantly downregulated in colorectal tumors [37].